BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Business

  Humanigen Appoints Rainer Boehm, M.D., to Board of Directors

  The new appointment is effective February 12, 2018.

  February 7, 2018

   · 

  3 min read
• BioCapital

  Dilon Technologies Announces the Launch of the New CoPilot VL+ Video Laryngoscope

  The new CoPilot VL+ boasts a larger, brighter, higher resolution display along with powerful LEDs to help the user obtain a better view of the airway.

  February 7, 2018

   · 

  2 min read
• Business

  Anavex Life Sciences Provides Clinical Programs Update and Reports Fiscal First Quarter 2018 Financial Results

  The company reported financial results for the three months ended December 31, 2017.

  February 7, 2018

   · 

  7 min read
• Business

  Elite Pharmaceuticals. to Host Conference Call to Discuss Third Quarter Financial Results on February 12, 2018

  Management will host a live conference call on Monday, February 12th at 11:30 AM EST to discuss the company’s financial and operating results and provide a general business update.

  February 7, 2018

   · 

  3 min read
• Business

  GN Store Nord: Double-Digit Growth in Revenue and Earnings – Delivered on Guidance – Feb. 7, 2018

  In 2017, revenue increased by 11% to DKK 9,585 million. Organic growth was 8%.

  February 7, 2018

   · 

  5 min read
• Business

  Ablynx Announces Board Changes - Feb. 7, 2018

  Dr Bo Jesper Hansen has decided to resign from the Board of Directors with immediate effect for personal reasons.

  February 7, 2018

   · 

  3 min read
• Drug Development

  Targovax Announces Completion of Safety Lead-In and Preliminary Immune Activation Data in ONCOS-102 Trial in Mesothelioma

  The trial is a randomized phase I/II open label trial, with a six-patient safety lead-in cohort, of ONCOS-102.

  February 7, 2018

   · 

  4 min read
• Business

  Pernix Announces Appointment of Lead Independent Director and Key Management Team Promotion

  The company announced the appointment of Director John R. Leone as its Lead Independent Director.

  February 7, 2018

   · 

  4 min read
• Business

  Natus Medical Announces Fourth Quarter and Full Year 2017 Financial Results

  For the fourth quarter ended December 31, 2017, the Company reported revenue of $131.4 million, an increase of 22.0% compared to $107.7 million reported for the fourth quarter 2016.

  February 7, 2018

   · 

  16 min read
• Drug Development

  Saniona Completes Recruitment in Phase I Study With New Tesomet tablet

  The trial is comprised of a total of 60 volunteers.

  February 7, 2018

   · 

  2 min read